Skip to main content

Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.

Publication ,  Journal Article
Holman, RR; Bethel, MA; Hernandez, AF
Published in: N Engl J Med
December 21, 2017

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

December 21, 2017

Volume

377

Issue

25

Start / End Page

2502

Location

United States

Related Subject Headings

  • Venoms
  • Peptides
  • Hypoglycemic Agents
  • Humans
  • Glycated Hemoglobin
  • General & Internal Medicine
  • Exenatide
  • Drug Administration Schedule
  • Diabetes Mellitus, Type 2
  • 42 Health sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Holman, R. R., Bethel, M. A., & Hernandez, A. F. (2017). Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med, 377(25), 2502. https://doi.org/10.1056/NEJMc1714163
Holman, Rury R., M Angelyn Bethel, and Adrian F. Hernandez. “Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med 377, no. 25 (December 21, 2017): 2502. https://doi.org/10.1056/NEJMc1714163.
Holman RR, Bethel MA, Hernandez AF. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Dec 21;377(25):2502.
Holman, Rury R., et al. “Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.N Engl J Med, vol. 377, no. 25, Dec. 2017, p. 2502. Pubmed, doi:10.1056/NEJMc1714163.
Holman RR, Bethel MA, Hernandez AF. Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2017 Dec 21;377(25):2502.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

December 21, 2017

Volume

377

Issue

25

Start / End Page

2502

Location

United States

Related Subject Headings

  • Venoms
  • Peptides
  • Hypoglycemic Agents
  • Humans
  • Glycated Hemoglobin
  • General & Internal Medicine
  • Exenatide
  • Drug Administration Schedule
  • Diabetes Mellitus, Type 2
  • 42 Health sciences